Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Sep;34(9):1699–1702. doi: 10.1128/aac.34.9.1699

Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery.

M G Bergeron 1, R Saginur 1, D Desaulniers 1, S Trottier 1, W Goldstein 1, P Foucault 1, C Lessard 1
PMCID: PMC171908  PMID: 2149493

Abstract

The concentrations of teicoplanin in sera and heart tissues of 49 patients undergoing coronary bypass were measured. Each patient received a 6- or 12-mg/kg dose of teicoplanin administered in a slow intravenous bolus injection over 3 to 5 min beginning at the time of induction of anesthesia. Mean +/- standard error of the mean concentrations in serum were, for the two doses, respectively, 58.1 +/- 1.7 and 123.3 +/- 7.4 micrograms/ml 5 min after administration and 22.2 +/- 0.7 and 56.5 +/- 2.8 micrograms/ml at the time of removal of atrial appendages. Mean +/- standard error of the mean concentrations in tissue were 70.6 +/- 1.7 and 139.8 +/- 2.2 micrograms/g, respectively, giving mean tissue/serum ratios of 3.7 +/- 0.3 and 2.8 +/- 0.2, respectively. Teicoplanin penetrates heart tissue readily and reaches levels in the serum far in excess of the MICs for most pathogens that have been found to cause infections following open heart surgery.

Full text

PDF
1699

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer G. L., Polk R. E., Duma R. J., Lower R. Comparison of cephalothin and cefamandole prophylaxis during insertion of prosthetic heart valves. Antimicrob Agents Chemother. 1978 Jun;13(6):924–929. doi: 10.1128/aac.13.6.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergeron M. G., Desaulniers D., Lessard C., Lemieux M., Després J. P., Métras J., Raymond G., Brochu G. Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery. Antimicrob Agents Chemother. 1985 Jun;27(6):928–932. doi: 10.1128/aac.27.6.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brion N., Lessana A., Mosset F., Lefevre J. J., Montay G. Penetration of pefloxacin in human heart valves. J Antimicrob Chemother. 1986 Apr;17 (Suppl B):89–92. doi: 10.1093/jac/17.suppl_b.89. [DOI] [PubMed] [Google Scholar]
  4. Cynamon M. H., Granato P. A. Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci. Antimicrob Agents Chemother. 1982 Mar;21(3):504–505. doi: 10.1128/aac.21.3.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Daschner F. D., Frank U., Kümmel A., Schmidt-Eisenlohr E., Schlosser V., Spillner H., Schuster B., Schindler M. Pharmacokinetics of vancomycin in serum and tissue of patients undergoing open-heart surgery. J Antimicrob Chemother. 1987 Mar;19(3):359–362. doi: 10.1093/jac/19.3.359. [DOI] [PubMed] [Google Scholar]
  6. Domart Y., Pierre C., Clair B., Garaud J. J., Regnier B., Gibert C. Pharmacokinetics of teicoplanin in critically ill patients with various degrees of renal impairment. Antimicrob Agents Chemother. 1987 Oct;31(10):1600–1604. doi: 10.1128/aac.31.10.1600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jadeja L., Fainstein V., LeBlanc B., Bodey G. P. Comparative in vitro activities of teichomycin and other antibiotics against JK diphtheroids. Antimicrob Agents Chemother. 1983 Aug;24(2):145–146. doi: 10.1128/aac.24.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kiss I. J., Faragó E., Gömöry A., Szamaránszky J. Investigations on the flucloxacillin levels in human serum, lung tissue, pericardial fluid and heart tissue. Int J Clin Pharmacol Ther Toxicol. 1980 Sep;18(9):405–411. [PubMed] [Google Scholar]
  9. Maderazo E. G., Breaux S. P., Woronick C. L., Quintiliani R., Nightingale C. H. High teicoplanin uptake by human neutrophils. Chemotherapy. 1988;34(3):248–255. doi: 10.1159/000238576. [DOI] [PubMed] [Google Scholar]
  10. Neu H. C., Labthavikul P. In vitro activity of teichomycin compared with those of other antibiotics. Antimicrob Agents Chemother. 1983 Sep;24(3):425–428. doi: 10.1128/aac.24.3.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Olson N. H., Nightingale C. H., Quintiliani R. Penetration characteristics of cefamandole into the right atrial appendage and pericardial fluid in patients undergoing open-heart surgery. Ann Thorac Surg. 1980 Feb;29(2):104–108. doi: 10.1016/s0003-4975(10)61644-x. [DOI] [PubMed] [Google Scholar]
  12. Thompson R. L., Cabezudo I., Wenzel R. P. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):309–317. doi: 10.7326/0003-4819-97-3-309. [DOI] [PubMed] [Google Scholar]
  13. Van der Auwera P., Matsumoto T., Husson M. Intraphagocytic penetration of antibiotics. J Antimicrob Chemother. 1988 Aug;22(2):185–192. doi: 10.1093/jac/22.2.185. [DOI] [PubMed] [Google Scholar]
  14. Verbist L., Tjandramaga B., Hendrickx B., Van Hecken A., Van Melle P., Verbesselt R., Verhaegen J., De Schepper P. J. In vitro activity and human pharmacokinetics of teicoplanin. Antimicrob Agents Chemother. 1984 Dec;26(6):881–886. doi: 10.1128/aac.26.6.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wilson A. P., Taylor B., Treasure T., Grüneberg R. N., Patton K., Felmingham D., Sturridge M. F. Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin. J Antimicrob Chemother. 1988 Feb;21(2):201–212. doi: 10.1093/jac/21.2.201. [DOI] [PubMed] [Google Scholar]
  16. Wilson A. P., Treasure T., Grüneberg R. N., Sturridge M. F., Ross D. N. Antibiotic prophylaxis in cardiac surgery: a prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacillin and tobramycin. J Antimicrob Chemother. 1988 Feb;21(2):213–223. doi: 10.1093/jac/21.2.213. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES